erdafitinib and Respiratory-Tract-Infections

erdafitinib has been researched along with Respiratory-Tract-Infections* in 1 studies

Other Studies

1 other study(ies) available for erdafitinib and Respiratory-Tract-Infections

ArticleYear
Use of Erdafitinib in
    JCO precision oncology, 2022, Volume: 6

    Topics: Humans; Papillomavirus Infections; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 3; Respiratory Tract Infections

2022